News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
Kalkine Market update
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
This page provides an interactive stock chart for MindWalk Holdings Corp. (HYFT) on Yahoo Finance. It displays a summary of their stock performance, recent news related to the company including earnings reports and AI drug discovery developments, and data on related tickers in the …
This article lists several healthcare stocks that experienced significant price movements during Friday's intraday trading session. Gainers include Tenet Healthcare (THC) and MindWalk Holdings (HYFT), while stocks like China SXT Pharmaceuticals (SXTC) and Catheter Precision (VTAK) saw substantial declines. The price changes are presented …
Issued on behalf of MindWalk Holdings Corp. (NASDAQ: HYFT) AUSTIN, Texas, July 24, 2026 /PRNewswire/ -- American News Group News Commentary - The race to bring artificial intelligence into drug discovery has become one of the most closely watched stories in both biotech and …
This page provides a comprehensive overview of MindWalk Holdings (HYFT) SEC filings, including annual 10-K reports, quarterly 10-Q reports, and material 8-K event disclosures. The company, a foreign private issuer, primarily files 6-K reports and is exempt from Section 16 Form 4 reporting. The …
At Advancing AI 2026, MindWalk unveils the first public demonstration of ReefIQ, its biological context layer for AI drug discovery, running on AMD Instinct™. AUSTIN, Texas, July 23, 2026--(BUSINESS WIRE)--MindWalk Holdings Corp. ("MindWalk") (NASDAQ: HYFT), a Bio-Native AI company, today unveiled the first public …
MindWalk Holdings Corp. (NASDAQ: HYFT) has reported a 46% increase in fiscal 2026 revenue to C$15.6 million, along with a significant reduction in net loss by more than half, signaling a successful pivot towards a recurring software business model. The company also secured its …
MindWalk Holdings Corp. (HYFT) reported a Q4 loss of $0.06 per share, missing the Zacks Consensus Estimate of a $0.05 loss, and revenues of $2.97 million, falling short of estimates by 8.8%. The company has not surpassed consensus EPS estimates in the last four …
MindWalk Holdings (NASDAQ: HYFT) announced preliminary fiscal 2026 results, reporting a 46% increase in revenue to C$15.6 million and a significant reduction in net loss from continuing operations to C$15.1 million. The company successfully completed its rebranding, divested a non-core subsidiary for C$14.3 million, …
MindWalk (HYFT) reported its Q4 2026 earnings, highlighting a transformative year focused on Bio-Native AI infrastructure for drug discovery, resulting in its first recurring platform revenue. The company achieved significant financial growth, with revenue up 46% year-over-year and gross margin expanding to 59%, while …
H.C. Wainwright has reiterated a Buy rating and a $5.00 price target for MindWalk Holdings (NASDAQ:HYFT), citing strong operational momentum and significant upside potential from the current stock price of $1.46. The firm projects total revenue of C$15.9 million for fiscal year 2026, with …
MindWalk Holdings Corp. CEO Dr. Jennifer Bath will join a virtual panel hosted by Jones AI Day on June 15, 2026, alongside Absci and a leading AI compute provider. The panel, "Partnering to Power the New Era of Drug Discovery," will discuss how advanced …
MindWalk Holdings Corp. (HYFT) is slated to release its Q4'25 earnings on July 22, 2026, after the market closes. Analysts estimate the company's revenue for Q4'25 to be $3.25 million, with an anticipated EPS of ($0.05). The article provides a detailed historical overview of …
Search by ticker symbol or company name and select a result to open its chart.